BioPharma Credit (BPCR) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free BPCR Stock Alerts GBX 0.88 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Affirmed for Benitec Biopharma Following Promising BB-301 Trial Results and Financial Boostmarkets.businessinsider.com - April 22 at 5:07 AMSapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) Stockinsidertrades.com - March 28 at 1:35 AMBioPharma Credit PLC (BPCP.L)nz.finance.yahoo.com - February 26 at 11:40 PMInvestors in BioPharma Credit (LON:BPCR) have seen notable returns of 40% over the past five yearsfinance.yahoo.com - February 22 at 8:12 AMBiopharma Credit just downgraded at Jefferies, here's whyrealmoney.thestreet.com - February 7 at 4:24 PMAssessing Ambrx Biopharma: Insights From 7 Financial Analystsmarkets.businessinsider.com - January 9 at 3:20 PMBioPharma Credit Ord (BPCR.L)finance.yahoo.com - January 8 at 2:09 AMBioPharma Credit to fund LumiraDx ahead of acquisition by Rochelse.co.uk - January 2 at 7:21 AMBioPharma Credit PLC (LON:BPCR) Looks Interesting, And It's About To Pay A Dividendfinance.yahoo.com - December 3 at 3:02 AMTruist Securities Downgrades POINT Biopharma Global (PNT)msn.com - October 4 at 10:43 PMBioPharma Credit notes liquidity amendments to LumiraDX loan deallse.co.uk - September 19 at 1:11 PMConnect Biopharma Reports First Half 2023 Financial Results and Provides Business Updatebenzinga.com - September 12 at 6:20 PMInvesting in BioPharma Credit (LON:BPCR) five years ago would have delivered you a 19% gainfinance.yahoo.com - August 27 at 9:13 AMLumiraDx Inc: LumiraDx Reports Second Quarter 2023 Resultsfinanznachrichten.de - August 24 at 11:57 PMBest Credit Cards For Recent College Graduates In August 2023forbes.com - August 16 at 2:23 AMABVC Biopharma Shares Drop 15% After Big Rise Tuesdaymarketwatch.com - August 2 at 12:34 PMCantor Fitzgerald Maintains Reata Pharmaceuticals Inc - (RETA) Overweight Recommendationmsn.com - July 25 at 7:27 AMBest Mobile Credit Card Readers Of 2023forbes.com - July 23 at 9:38 AMTD Cowen Initiates Coverage of Reata Pharmaceuticals Inc - (RETA) with Outperform Recommendationmsn.com - July 6 at 2:04 PMDRI Healthcare Trust says CTI BioPharma repaid $54.8M debtmsn.com - June 26 at 6:34 PMThis stock could become a 'one-stop shop' for biopharma and rally more than 35%, RBC sayscnbc.com - June 21 at 12:56 PMHear how Cambrian BioPharma is reinventing drug (and drug company) developmentmsn.com - May 3 at 12:24 AMBioPharma Credit PLC (LON:BPCR) Passed Our Checks, And It's About To Pay A US$0.018 Dividendfinance.yahoo.com - April 23 at 9:43 AMBioPharma Credit's (LON:BPCR) investors will be pleased with their notable 42% return over the last three yearsfinance.yahoo.com - March 20 at 9:03 AMAmbrx Biopharma Shares Rise 7% After Completing ATM Programmarketwatch.com - March 13 at 5:57 PMThe next big wave of patent cliffs is ahead; expect biopharma M&A to rise – reportmsn.com - February 19 at 1:44 PMHillstream BioPharma Shares Rise 15% After Licensing Dealmarketwatch.com - February 13 at 10:13 PMBenzinga's Top Ratings Upgrades, Downgrades For February 13, 2023msn.com - February 13 at 12:12 PMHillstream BioPharma Shares Soar on Positive Lung Cancer Treatment Resultsmarketwatch.com - February 10 at 9:26 AMFirst Wave BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirementtechnews.tmcnet.com - February 7 at 2:19 PMHillstream BioPharma Shares Double After Option Agreement With Dana-Farber Cancer Institutemarketwatch.com - January 31 at 2:01 PMBPCR.L - | Stock Price & Latest News | Reutersreuters.com - January 15 at 7:48 PMFirst Wave BioPharma Announces Initial Clinical Sites for its Phase 2 Trial of Enhanced Microgranule Delivery Formulation of Adrulipasetechnews.tmcnet.com - December 5 at 7:30 AMInvestors in BioPharma Credit (LON:BPCR) have made a return of 19% over the past five yearsfinance.yahoo.com - October 1 at 11:17 AMBioPharma Credit PLC (LON:BPCR) Goes Ex-Dividend Soonfinance.yahoo.com - August 21 at 8:27 AMBioPharma Credit (LON:BPCR) Has Announced A Dividend Of $0.0175finance.yahoo.com - August 19 at 4:16 AMBioPharma Credit PLC (BPCR.L)uk.finance.yahoo.com - August 17 at 9:55 PMWhy CTI BioPharma Stock Got Rocked on Tuesdaymsn.com - August 9 at 7:02 PMPfizer to buy Global Blood Therapeutics for US$5.4bnproactiveinvestors.com - August 9 at 9:38 AMIs Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?finance.yahoo.com - August 8 at 5:43 PMBioPharma Credit PLC's (LON:BPCR) Popularity With Investors Is Under Threat From Overpricingfinance.yahoo.com - July 18 at 5:38 AMDEM BioPharma Launches with $70 Million Financingfinance.yahoo.com - June 23 at 8:37 PMDEM BioPharma launches with $70m to take a bite out of cancermsn.com - June 23 at 9:56 AMHillstream BioPharma Provides Corporate Updateyahoo.com - June 2 at 10:05 AMABVC BioPharma, Inc. Announces $4.22 Million Registered Direct Offeringapnews.com - May 12 at 9:30 AMBioPharma Credit Shareholder to Sell 55 Mln Shares via Bookbuild Programmarketwatch.com - April 20 at 10:17 AMBioPharma Credit to Invest Up to $50 Mln in UroGen Pharmamarketwatch.com - March 8 at 1:44 PMBiopharma Cred. Share Chatlse.co.uk - February 3 at 11:57 PMBioPharma Credit to Apply for Admission to Listing on LSE Main Market's Premium Segmentmarketwatch.com - September 10 at 4:10 AMBioPharma Credit PLC - Holding(s) in Companyproactiveinvestors.com - August 30 at 10:21 PM Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. BPCR Media Mentions By Week BPCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPCR News Sentiment▼0.800.31▲Average Financial Services News Sentiment BPCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPCR Articles This Week▼10▲BPCR Articles Average Week Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KRM22 News Adams News i(x) Net Zero News Tetragon Financial News Princess Private Equity News Tekcapital News London Finance & Investment Group News Tanfield Group News Investment News Seed Innovations News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:BPCR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
